Skip to main content
Home
language-selector-globe Czech Republic | en
Choose Location
language-selector-globe Czech Republic |
CzechEnglish
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | es
Brazil | pt
Canada | en
Canada | fr
Central America | es
Colombia | es
Mexico | es
United States | en
Venezuela | es
Australia | en
Bangladesh | en
Hong Kong S.A.R. | zh
India | en
Indonesia | en
Japan | ja
Korea | ko
Mainland China | zh
Malaysia | en
Pakistan | en
Philippines | en
Singapore | en
Taiwan | zh
Austria | de
Belgium | fr
Belgium | nl
Bulgaria | bg
Czech Republic | cs
Czech Republic | en
Denmark | da
Estonia | et
Finland | fi
France | fr
Germany | de
Greece | el
Hungary | hu
Ireland | en
Italy | it
Latvia | lv
Lithuania | lt
Netherlands | nl
Norway | no
Poland | pl
Portugal | pt
Romania | ro
Russia | ru
Serbia | sr
Slovakia | sk
Spain | es
Sweden | sv
Switzerland | de
Switzerland | fr
United Kingdom | en
Global | en
Novartis Foundation | en
Sandoz | en
Egypt | en
Israel | he
South Africa | en
Turkey | tr
language-selector-globe Czech Republic
Choose Location
language-selector-globeCzech Republic
CzechEnglish
Americas Asia Pacific Europe International Middle East & Africa
Argentina | es
Australia | en
Austria | de
Bangladesh | en
Belgium | fr
Belgium | nl
Brazil | pt
Bulgaria | bg
Canada | en
Canada | fr
Central America | es
Colombia | es
Czech Republic | cs
Czech Republic | en
Denmark | da
Egypt | en
Estonia | et
Finland | fi
France | fr
Germany | de
Global | en
Greece | el
Hong Kong S.A.R. | zh
Hungary | hu
India | en
Indonesia | en
Ireland | en
Israel | he
Italy | it
Japan | ja
Korea | ko
Latvia | lv
Lithuania | lt
Mainland China | zh
Malaysia | en
Mexico | es
Netherlands | nl
Norway | no
Novartis Foundation | en
Pakistan | en
Philippines | en
Poland | pl
Portugal | pt
Romania | ro
Russia | ru
Sandoz | en
Serbia | sr
Singapore | en
Slovakia | sk
South Africa | en
Spain | es
Sweden | sv
Switzerland | de
Switzerland | fr
Taiwan | zh
Turkey | tr
United Kingdom | en
United States | en
Venezuela | es
    • About 
      • Novartis in the Czech Republic 
      • Strategy 
      • Diversity and inclusion 
      • People and culture 
      • Products 
      • Country leadership team 
      • Our mission and vision 
      • Innovative medicines 
      • Contact 
      Novartis Česká republika About
    • Patients and caregivers 
      • Novartis commitment to patients and caregivers 
      • Our patient portals for Czech Republic 
      • Products 
      • Adverse event reporting 
      • Provision of gifts and grants 
      Babička s vnučkou v objetí Patients and Caregivers
    • Healthcare professionals 
      • Healthcare professional country resource 
      • Products 
      • Novartis pipeline 
      • Adverse event reporting 
      • Novartis clinical trials 
        • Clinical trials in Czech Republic 
      • VPOIS 
      • Expert information 
      Vědec se dívá do mikroskopu Healthcare Professionals
    • Research and development 
      • Research and development in Czech Republic 
      Vědkyně v laboratoři Research and development
    • ESG 
      • Ethics, risk and compliance 
      • Access 
      • Environmental sustainability 
      • Global health 
      • Ethical behavior 
      • Whistleblow line 
      Ruka na rozpukané vyprahlé hlíně ESG
    • News 
      • News archive 
      • Stories 
      • Media library 
      • Media contacts 
      Diskutující lidé s notebooky nad odbornými články News
    • Careers 
      • Career search 
      • Meet the teams 
      • Personal growth 
      • Early talent 
      • How we work 
      • Leadership trainee program 
      • Well-being 
      • Diversity and inclusion 
      • Awards and recognition 
      Usmívající se žena v posluchárně Careers
    • Coronavirus 
      Částice viru SARS CoV 2 na snímku z elektronového mikroskopu. Coronavirus
    Female scientist in laboratory Home
  1. Home
  2. Careers
  3. Career Search
  • Sort by Sort ascending
  • Job Title
  • Site Sort descending
  • Location
  • Division
  • Business
  • Functional Area
  • Date Posted
Job Title Site Sort descending Location Division Business Functional Area Date Posted
县域主任(主管) Luoyang (Henan Province) China International Innovative Medicines Sales Sep 26, 2024
县域主任/县域主管 Luoyang (Henan Province) China International Innovative Medicines Sales Jun 04, 2024
县域主任(主管) Luoyang (Henan Province) China International Innovative Medicines Sales Sep 26, 2024
(高级)医药代表 /(资深)产品专员 Luzhou (Sichuan Province) China International Innovative Medicines Sales Apr 09, 2024
County Executive Maoming (Guangdong Province) China International Innovative Medicines Sales Jul 30, 2024
(高级)医药代表 /(资深)产品专员 Nanjing (Jiangsu Province) China International Innovative Medicines Sales Oct 10, 2024
(高级)医药代表 /(资深)产品专员 Nanjing (Jiangsu Province) China International Innovative Medicines Sales Oct 10, 2024
(高级)医药代表 /(资深)产品专员 Nanjing (Jiangsu Province) China International Innovative Medicines Sales Oct 10, 2024
(高级)医药代表 /(资深)产品专员 Nanjing (Jiangsu Province) China International Innovative Medicines Sales Oct 10, 2024
(高级)医药代表 /(资深)产品专员 Nanjing (Jiangsu Province) China International Innovative Medicines Sales Oct 10, 2024
(高级)医药代表 /(资深)产品专员 Nanjing (Jiangsu Province) China International Innovative Medicines Sales Oct 10, 2024
(高级)医药代表 /(资深)产品专员 Nanjing (Jiangsu Province) China International Innovative Medicines Sales Oct 10, 2024
(高级)医药代表 /(资深)产品专员 Nanjing (Jiangsu Province) China International Innovative Medicines Sales Oct 10, 2024
SALES Nanjing (Jiangsu Province) China International Innovative Medicines Sales Oct 15, 2024
(高级)医药代表 /(资深)产品专员 Nanyang (Henan Province) China International Innovative Medicines Sales Aug 23, 2024
县域主任(主管) Nanyang (Henan Province) China International Innovative Medicines Sales Sep 26, 2024
County Executive Ningde (Fujian Province) China International Innovative Medicines Sales May 06, 2024
County Executive Ningde (Fujian Province) China International Innovative Medicines Sales May 06, 2024
County Executive Ningde (Fujian Province) China International Innovative Medicines Sales May 06, 2024
County Executive Ningde (Fujian Province) China International Innovative Medicines Sales May 06, 2024
County Executive Ningde (Fujian Province) China International Innovative Medicines Sales May 06, 2024
County Executive Ningde (Fujian Province) China International Innovative Medicines Sales May 06, 2024
County Executive Ningde (Fujian Province) China International Innovative Medicines Sales May 06, 2024
County Executive Ningde (Fujian Province) China International Innovative Medicines Sales May 06, 2024
MR Pingxiang (Jiangxi Province) China International Innovative Medicines Sales Sep 23, 2024
MR Pingxiang (Jiangxi Province) China International Innovative Medicines Sales Sep 23, 2024
MR Pingxiang (Jiangxi Province) China International Innovative Medicines Sales Sep 23, 2024
MR Pingxiang (Jiangxi Province) China International Innovative Medicines Sales Sep 23, 2024
MR Pingxiang (Jiangxi Province) China International Innovative Medicines Sales Sep 23, 2024
MR Pingxiang (Jiangxi Province) China International Innovative Medicines Sales Sep 23, 2024
MR Pingxiang (Jiangxi Province) China International Innovative Medicines Sales Sep 23, 2024
MR Pingxiang (Jiangxi Province) China International Innovative Medicines Sales Sep 23, 2024
(高级)医药代表 /(资深)产品专员 Qingyuan (Guangdong Province) China International Innovative Medicines Sales Jul 01, 2024
(高级)医药代表 /(资深)产品专员 Qinnan (Guizhou Province) China International Innovative Medicines Sales Aug 04, 2024
Executive Product Specialist Quanzhou (Fujian Province) China International Innovative Medicines Sales Sep 18, 2024
县域主任/县域主管 Qujing (Yunnan Province) China International Innovative Medicines Sales Oct 09, 2024
县域主任/主管 Sanmenxia (Henan Province) China International Innovative Medicines Sales May 07, 2024
县域主任(主管) Sanmenxia (Henan Province) China International Innovative Medicines Sales Oct 16, 2024
Medical Advisor Shanghai (Shanghai) China International Innovative Medicines Research & Development Jul 15, 2024
RLT HCS & Partnerships Head Shanghai (Shanghai) China International Innovative Medicines Marketing Sep 03, 2024
Sr Manager/Manager-Monitoring Shanghai (Shanghai) China Ethics Risk & Compliance Innovative Medicines Legal & Intellectual Property & Compl. Jul 18, 2024
Senior Brand Manager Shanghai (Shanghai) China International Innovative Medicines Marketing Apr 16, 2024
MSL Manager, RLT Shanghai (Shanghai) China International Innovative Medicines Research & Development Apr 18, 2024
Sr. Manager DDIT GF Sol.Del. China Shanghai (Shanghai) China Operations CTS Technology Transformation Sep 03, 2024
Senior Brand Manager Shanghai (Shanghai) China International Innovative Medicines Marketing Apr 29, 2024
Senior Marketing Manager Shanghai (Shanghai) China International Innovative Medicines Marketing May 15, 2024
Head of Customer Strategy & Operations Shanghai (Shanghai) China International Innovative Medicines Marketing Sep 03, 2024
Principal Biostatistician Shanghai (Shanghai) China Development Innovative Medicines Research & Development Jun 20, 2024
(高级)地区经理 Shanghai (Shanghai) China International Innovative Medicines Sales Jun 21, 2024
Senior Legal Counsel Shanghai (Shanghai) China Legal Innovative Medicines Legal & Intellectual Property & Compl. Jul 02, 2024

Pagination

  • ‹ Previous page
  • 1
  • …
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • …
  • 12
  • › Next page

Novartis Czech Republic

Navigate Novartis
  • Patients & caregivers
  • Healthcare professionals
  • ESG
  • News
  • Careers
  • Adverse event reporting
Media Center
  • News archive
  • Stories
Our Portfolio
  • Novartis clinical pipeline
  • Novartis product portfolio
Other Novartis websites
  • Global
Footer Bottom
© 2024 Novartis s.r.o
  • Privacy Policy
  • Terms of Use
  • Cookie Settings
  • Site Map
  • Web Accessibility
Novartis Site Directory
This site is intended for an audience in the Czech Republic